Form D · Biotechnology
GIOCOV Ltd
London, X0 · CIK 0001862244
Offering snapshot reported Jan 12, 2022 · SEC filing
- Reported sold
- $1.2M Indefinite offering
- Investors reported
- 0 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Nov 1, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 12, 2022 | Amendment | $1,200,000 | No comparison | 0 | SEC filing |
| May 14, 2021 | Initial | Yet to sell | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt
- Exemptions
- 06c
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $2.1M (estimated)
- Finders' fees
- $500K (estimated)
- Form D file number
- 021-399390
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| TAG Investment Bankers Ltd | None |
Source: Form D, filed Jan 12, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Deven Patel | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
20 22 Wenlock Road
London, X0, N1 7GU
London, X0, N1 7GU